首页> 外国专利> METHOD FOR PREDICTING KAWASAKI DISEASE SYMPTOMS BY USING HMGB1, ITPKC, OR SLC11A1 GENE POLYMORPHISM

METHOD FOR PREDICTING KAWASAKI DISEASE SYMPTOMS BY USING HMGB1, ITPKC, OR SLC11A1 GENE POLYMORPHISM

机译:HMGB1,ITPKC或SLC11A1基因多态性预测川崎病症状的方法

摘要

The present invention relates to a method for predicting Kawasaki disease symptoms by using a HMGB1 gene polymorphism. Kawasaki disease is an acute febrile rash that occurs primarily in infants and toddlers younger than 5 years old and can cause the formation of coronary artery lesions when not treated with the proper use of intravenous immunoglobulin (IVIG).However, patients with Kawasaki disease show resistance to IVIG in many cases, making treatment difficult.A method for predicting Kawasaki disease symptoms by using a HMGB1 gene polymorphism, of the present invention, determines the correlation between the HMGB1 gene and Kawasaki disease symptoms and enables the possibility of coronary artery lesion formation or the possibility of IVIG resistance in patients with Kawasaki disease to be predicted in advance, and thus is expected to be widely used in the medical field.In addition, the present invention relates to a method for predicting the onset of Kawasaki disease by using ITPKC and SLC11A1 gene polymorphisms. Kawasaki disease is an acute febrile rash occuring primarily in infants and toddlers younger than 5 years old and can cause the formation of coronary artery lesions, and Kawasaki disease is known to be the most common cause of acquired heart disease in developed countries. However, until now, no specific test for diagnosing Kawasaki disease has existed such that diagnosis thereof has only been made according to clinical criteria, and thus management is achieved only by post-treatment and not by prevention.A method for predicting the onset of Kawasaki disease by using ITPKC and SLC11A1 gene polymorphisms, of the present invention, is applied to the correlation, specified in Koreans, between ITPKC and SLC11A1 genes and to synergistic effects thereby in the onset of Kawasaki disease, and enables possibility of onset to be predicted before the onset of Kawasaki disease, and thus is expected to be widely used in the medical field.
机译:本发明涉及通过使用HMGB1基因多态性来预测川崎病症状的方法。川崎病是一种急性发热性皮疹,主要发生在5岁以下的婴幼儿中,如果不适当使用静脉免疫球蛋白(IVIG)治疗,会导致冠状动脉病变的形成。但是,川崎病患者在许多情况下均表现出对IVIG的耐药性,使治疗变得困难。本发明的通过使用HMGB1基因多态性来预测川崎病症状的方法,确定了HMGB1基因与川崎病症状之间的相关性,并且使得患有川崎病的患者能够形成冠状动脉病变或IVIG抵抗的可能性。预先进行预测,因此有望在医疗领域广泛使用。另外,本发明涉及通过使用ITPKC和SLC11A1基因多态性来预测川崎病发病的方法。川崎病是一种急性发热性皮疹,主要发生在5岁以下的婴幼儿中,并可能导致冠状动脉病变的形成,而川崎病是发达国家中获得性心脏病的最常见原因。然而,直到现在,还没有用于诊断川崎病的具体测试,使得仅根据临床标准对其进行诊断,因此仅通过后处理而不是通过预防来实现管理。本发明的通过使用ITPKC和SLC11A1基因多态性来预测川崎病发作的方法,被应用于韩国人中ITPKC和SLC11A1基因之间的相关性,并由此产生了协同作用,从而引发了川崎病。能够在川崎病发病之前预测发病的可能性,因此有望在医学领域得到广泛使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号